|
Evaluation, Treatment, and Training for Patients with Blood Disorders Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Evaluation, Treatment, and Training for Patients with Blood Disorders conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Evaluation, Treatment, and Training for Patients with Blood Disorders Clinical research trials and Evaluation, Treatment, and Training for Patients with Blood Disorders healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Evaluation, Treatment, and Training for Patients with Blood Disorders. Evaluation, Treatment, and Training for Patients with Blood Disorders Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Evaluation, Treatment, and Training for Patients with Blood Disorders clinical trial. Subjects frequently obtain the most expert healthcare possible for their Evaluation, Treatment, and Training for Patients with Blood Disorders condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Evaluation, Treatment, and Training for Patients with Blood Disorders  Evaluation, Treatment, and Training for Patients with Blood Disorders
Evaluation, Treatment, and Training for Patients with Blood Disorders
For Condition: Hematologic Disease,Hematologic Neoplasm,Pancytopenia
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: This study is designed to allow the evaluation, follow-up, and medical care of patients with blood disorders not currently participating in a research study being conducted by the Hematology Branch of the National Heart, Lung and Blood Institute (NHLBI) or not being screened for participation in a study. The purpose of this study is to allow investigation into the blood disorders of patients in order to teach, learn, and gather more information about diseases of the blood. In addition, this study allows researchers the opportunity to evaluate patients referred to the Hematology Branch of the NHLBI with rare or undiagnosed diseases of the blood. This may be potentially beneficial to the patient and at the same time contribute to the development of new research ideas.
Details: This protocol is designed to allow the evaluation, follow up, and standard medical care of patients with bone marrow failure states, cytopenias, metastatic solid tumors, or hematologic malignancies not currently entered on an active NHLBI Hematology Branch protocol or not being screened for an active NHLBI research protocol. Its purpose is to allow investigation into the hematologic problems of these patients for the primary purpose of teaching and furthering general hematologic knowledge. The ability to evaluate and treat patients with a wide variety of hematologic disease is critical to maintaining our accreditation as a hematology fellowship program and training our fellows to be competent hematologists, as well as for keeping all staff, including senior staff, up-to-date and familiar with the evaluation and treatment of patients with a wide spectrum of hematologic disease. It also allows the Hematology Branch to evaluate patients referred with rare or as yet undiagnosed hematologic problems, both potentially benefitting the patient and stimulating new research directions for the Hematology Branch in the future. Periodic follow-up and treatment of patients previously entered on Hematology Branch protocols in order to monitor the long-term course of the underlying hematologic state and the consequences of experimental treatments is also required for fellowship training, and for maintenance of good referral relationships with patients and their physicians.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Patients may be entered on this protocol at the discretion of the Principal and/or Associate Investigators if : The subject is not currently enrolled on another active Hematology Branch research protocol. AND An investigator decides that it is in the best interest of the patient and the Branch for the patient to be enrolled in this protocol while awaiting a decision on eligibility for other protocols, or after completion of another protocol, or to allow careful evaluation of patients with unique or rare disorders of direct interest to the Branch or with more common disorders for fellowship teaching purposes. The patient or the patient's guardian is capable of informed consent and signs the consent form. The consent form will be signed by parents or guardians of patients under the age of 18. Age greater than or equal to 2 and weight greater than 12 kg.
Total Enrollment: 9999999
Location and Contact Information:
National Heart, Lung and Blood Institute (NHLBI) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 940010; 94-H-0010
Study Start Date: October 19, 1993
Record last reviewed: October 10, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001397
Other Pancytopenia Studies:
1. The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells from Normal Volunteers and Volunteers with Lymphoid or Hematologic Malignancies
2. Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia
3. Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
4. Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients with Blood Cancer
5. Evaluation, Treatment, and Training for Patients with Blood Disorders
Related Studies:
Other Pancytopenia Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Evaluation, Treatment, and Training for Patients with Blood Disorders
|
|
|
|
|
|
|
|
